Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Vaccination

Cut off age for meningitis B vaccine will not change, committee says

The Joint Committee on Vaccination and Immunisation (JCVI), which advises UK health departments on immunisation, has recommended that the meningitis B vaccine should not be extended to all UK children under the age of two.

The vaccine was introduced in September 2015 for babies aged up to 12 months in whom it was deemed to be marginally cost effective. However, a petition signed by more than 800,000 people calling for the vaccine to be given to all children under the age of 11 prompted the JCVI to consider the effectiveness of a “small-scale” catch-up programme for children aged 12 to 23 months.

The committee made its decision using real-world data from the first few months of the UK’s Bexsero vaccination programme for children up to 12 months – which is the first meningitis B vaccination programme in the world.

The JCVI has concluded that while a programme to vaccinate children aged 12–23 months of age could be cost effective, there was insufficient vaccine available.

“There was unlikely to be any vaccine available… to those aged 12 to 23 months of age before the 2016/17 meningococcal season,” it said, therefore a decision to increase the age limit would require the use of Public Health England’s buffer stocks.

The committee also expressed concerns “about the serious risks to the infant programme that the use of Public Health England’s buffer stock could present”, and as a consequence agreed that “they could not advise the Department of Health to consider such a catch-up programme”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201441

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Young baby asleep

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.